Medical Director, Innovation & Strategy – Molecular Imaging

Medical Director, Innovation & Strategy – Molecular Imaging page is loaded## Medical Director, Innovation & Strategy – Molecular Imaging remote type:
Hybrid locations:
Needham, Massachusetts, 02494, USAtime type:
Full time posted on:
Posted Todayjob requisition
*** About Blue Earth Diagnostics:
*** Blue Earth Diagnostics is an established molecular imaging company focused on providing innovative, well-differentiated diagnostics solutions, informing patient management, and driving future therapies in cancer. Formed in 2014, Blue Earth Diagnostics’ success is driven by our management expertise and agility, supported by our demonstrated track record of rapid development and commercialization of PET radiopharmaceuticals. Blue Earth Diagnostics’ clinical focus is exclusively in cancer.

Blue Earth Diagnostics is a subsidiary of Bracco Imaging S.p.A., a global leader in diagnostic imaging.

Blue Earth Diagnostics is an established molecular imaging company focused on providing innovative, well-differentiated diagnostics solutions, informing patient management, and driving future therapies in cancer. Formed in 2014, Blue Earth Diagnostics’ success is driven by our management expertise and agility, supported by our demonstrated track record of rapid development and commercialization of PET radiopharmaceuticals. Blue Earth Diagnostics’ clinical focus is exclusively in cancer.

Blue Earth Diagnostics is a subsidiary of Bracco Imaging S.p.A., a global leader in diagnostic imaging.

- ** Job Purpose
** Reporting to the VP Innovation and Strategy, the Medical Director, Innovation and Strategy – Molecular Imaging will be the global medical lead for new asset evaluations for molecular imaging product pipeline expansion. They will play a key role in the technical and commercial assessment of novel radiopharmaceutical product opportunities, both in oncology and other disease areas (such as cardiology and neurology).

This Medical Director, Innovation and Strategy – Molecular Imaging will provide a global perspective of unmet medical needs and critically review potential new assets from a medical perspective, including delivering on advisory boards and market research activities, and undertaking due diligence activities such as product development program design and validation of the regulatory strategy. The role will require cross-functional collaboration with BED and other Bracco MI colleagues, as well as across Bracco functions, such as Global R&D and Global Medical and Regulatory Affairs.

This position will operate on a hybrid work schedule, with the expectation of working onsite 3 days a week in our office located at 197 First Avenue, Needham, MA.
** Main Responsibilities, Activities, Duties and Tasks
*** Serve as the Medical Lead within the Blue Earth Diagnostics Innovation and Strategy team:  + Work closely with the VP Innovation and Strategy and New Assets Evaluation Team to develop and maintain a clear view of emerging global trends in the molecular imaging radiopharmaceutical landscape, to define promising areas of clinical unmet need for future investment focus  + Develop and maintain a good understanding of current business product portfolio within the broader context of the molecular imaging landscape  + Leverage both internal and external resources to provide a critical medical review during the evaluation of potential new assets for the Blue Earth Diagnostics product pipeline.

This includes delivering on advisory boards and supporting on market research activities.  + Work within the New Assets Evaluation team and with cross-functional team members, to successfully execute due diligence activities on specific new asset opportunities, such as validation of the existing global regulatory strategy, risk assessment and potential mitigation approaches relating to the medical aspects, product development program design with cost estimates and business case validation.  

+ Communicate new asset opportunity evaluation considerations and recommendations, particularly relating to global clinical unmet needs and clinical development plans, accurately and clearly to a wider variety of stakeholders (including within the…